Hematol Oncol Clin North Am. 2008 Oct;22(5):941-52, ix.

Diffuse large B-cell lymphoma.

Source

James P. Wilmot Cancer Center, University of Rochester, 601 Elmwood Avenue, Box 704, Room 1-4118C, Rochester, NY 14642, USA. jonathan_friedberg@urmc.rochester.edu

Abstract

Diffuse large B-cell lymphoma (DLBCL) remains a curable lymphoma, with improved outcome resulting in large part from the incorporation of rituximab in standard regimens. The disease is heterogeneous clinically, morphologically, and molecularly. Recent insights into the molecular heterogeneity of DLBCL are beginning to yield novel therapeutics with significant promise for key subsets of patients. Although cyclophosphamide, hydroxydaunorubicin, vincristine, and prednisone chemotherapy with rituximab remains a standard therapeutic approach for most patients who have DLBCL, it is anticipated that novel agents will be included in treatment regimens for many patients in the near future.

PMID:: 18954744; [PubMed - indexed for MEDLINE]
PMCID:: PMC2593154

Free PMC Article

Images from this publication.See all images (2) Free text

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Lymphoma - MedlinePlus Health Information

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

The prognostic value of immunohistochemical subtyping in Chinese patients with de novo diffuse large B-cell lymphoma undergoing CHOP or R-CHOP treatment. [Ann Hematol. 2010]
The prognostic value of immunohistochemical subtyping in Chinese patients with de novo diffuse large B-cell lymphoma undergoing CHOP or R-CHOP treatment.
Xia ZG, Xu ZZ, Zhao WL, Zhao SQ, Ding F, Chen Y, Chen QS, Zheng Y, Zhu Q, Hu JP, et al. Ann Hematol. 2010 Feb; 89(2):171-7. Epub 2009 Aug 11.
Review Treatment of aggressive non-Hodgkin's lymphoma: a north American perspective. [Oncology (Williston Park). 2005]
Review Treatment of aggressive non-Hodgkin's lymphoma: a north American perspective.
Sehn LH, Connors JM. Oncology (Williston Park). 2005 Apr; 19(4 Suppl 1):26-34.
Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma. [J Clin Oncol. 2008]
Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.
Fu K, Weisenburger DD, Choi WW, Perry KD, Smith LM, Shi X, Hans CP, Greiner TC, Bierman PJ, Bociek RG, et al. J Clin Oncol. 2008 Oct 1; 26(28):4587-94. Epub 2008 Jul 28.
Review Recent advances in the understanding and management of diffuse large B-cell lymphoma in children. [Br J Haematol. 2008]
Review Recent advances in the understanding and management of diffuse large B-cell lymphoma in children.
Reiter A, Klapper W. Br J Haematol. 2008 Jul; 142(3):329-47. Epub 2008 Jun 3.
Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP. [Blood. 2008]
Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP.
Malumbres R, Chen J, Tibshirani R, Johnson NA, Sehn LH, Natkunam Y, Briones J, Advani R, Connors JM, Byrne GE, et al. Blood. 2008 Jun 15; 111(12):5509-14. Epub 2008 Apr 29.

See reviews... See all...

Cited by 3 PubMed Central articles

Lymphoproliferative Lesions in the Setting of HIV Infection: A Five-Year Retrospective Case Series and Review. [Patholog Res Int. 2011]
Lymphoproliferative Lesions in the Setting of HIV Infection: A Five-Year Retrospective Case Series and Review.
Mahe E, Ross C, Sur M. Patholog Res Int. 2011 Mar 30; 2011:618760. Epub 2011 Mar 30.
Review Novel therapeutics for aggressive non-Hodgkin's lymphoma. [J Clin Oncol. 2011]
Review Novel therapeutics for aggressive non-Hodgkin's lymphoma.
Mahadevan D, Fisher RI. J Clin Oncol. 2011 May 10; 29(14):1876-84. Epub 2011 Apr 11.
Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype. [J Clin Oncol. 2010]
Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype.
Morton LM, Curtis RE, Linet MS, Bluhm EC, Tucker MA, Caporaso N, Ries LA, Fraumeni JF Jr. J Clin Oncol. 2010 Nov 20; 28(33):4935-44. Epub 2010 Oct 12.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Diffuse large B-cell lymphoma.
Diffuse large B-cell lymphoma.
Hematol Oncol Clin North Am. 2008 Oct ;22(5):941-52, ix.

PubMed
Tissue transformation into bone in vivo. A potential practical application.
Tissue transformation into bone in vivo. A potential practical application.
JAMA. 1991 Oct 9 ;266(14):1953-5.

PubMed
Patient-controlled analgesia. Does a concurrent opioid infusion improve pain man...
Patient-controlled analgesia. Does a concurrent opioid infusion improve pain management after surgery?
JAMA. 1991 Oct 9 ;266(14):1947-52.

PubMed
Sepsis strategies in development.
Sepsis strategies in development.
Clin Chest Med. 2008 Dec ;29(4):735-47, x-xi.

PubMed
Medical comorbidities predict the need for colectomy for complicated and recurre...
Medical comorbidities predict the need for colectomy for complicated and recurrent diverticulitis.
Am J Surg. 2008 Nov ;196(5):710-4.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Diffuse large B-cell lymphoma.

Source

Abstract

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 3 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information